2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
How does cholesterol burden change the case for investing in Familial Hypercholesterolaemia? A cost-effectiveness analysis.
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Prevention and Treatment of Atherosclerosis – Improving State-of-the-Art Management and Search for Novel Targets
European Atherosclerosis Society Consensus Panel: New Statement on Triglyceride-Rich Lipoproteins and their Remnants
Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: levelling up access to treatment urgently needed
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement
